Company Filing History:
Years Active: 2013
Title: Rebecca Bischoff: Innovator in Cell Culture Technology
Introduction
Rebecca Bischoff is a notable inventor based in Warthausen, Germany. She has made significant contributions to the field of cell culture technology, particularly in biopharmaceutical production. With one patent to her name, Bischoff's innovative work is paving the way for advancements in the manufacturing of proteins.
Latest Patents
Rebecca Bischoff holds a patent titled "Use of HSA-producing cells". This invention focuses on methods for multiplying and cloning cells crucial to biopharmaceutical production. The patent describes methods for producing proteins and highlights the significance of cells extracted and multiplied via single cell sorting. Additionally, the invention outlines media compositions that facilitate the multiplication of single cells. By utilizing albumin-producing, specifically HSA-producing, cells as feeder cells or host cells, the recloning efficiency and quantity of clones can be significantly enhanced. This method proves beneficial in serum-free or insulin-free media and across various cell types.
Career Highlights
Rebecca Bischoff is affiliated with Boehringer Ingelheim Pharma GmbH & Co. KG, a renowned company in the pharmaceutical industry. Her expertise and innovation in cell culture technology marks a significant milestone in the development of biopharmaceuticals, demonstrating the practical application of her research.
Collaborations
Throughout her career, Rebecca has collaborated with esteemed colleagues, including Lore Florin and Juergen Fieder. Together, they contribute to advancing the understanding and technology of cell culture practices, enhancing the industry's capabilities in producing vital biopharmaceuticals.
Conclusion
Rebecca Bischoff's contributions to cell culture technology, particularly through her patent on HSA-producing cells, underscore her role as an innovative force in the biopharmaceutical field. Her work at Boehringer Ingelheim Pharma GmbH & Co. KG, alongside her colleagues, highlights the importance of collaboration in driving forward scientific advancements that benefit healthcare and technology.